期刊文献+

多囊卵巢综合征患者促甲状腺激素浓度与血脂关系的研究 被引量:10

Association between thyroid-stimulating hormone and serum lipid in patients with polycystic ovary syndrome
下载PDF
导出
摘要 目的研究不同浓度血清促甲状腺激素(thyroid-stimulating hormone,TSH)的多囊卵巢综合征(polycystic ovary syndrome,PCOS)患者临床特征及内分泌代谢指标之间的差异。方法选择110例多囊卵巢综合征患者,测量身高、体质量、腰围、臀围;应用化学发光法分析测定血清TSH、总胆固醇(total cholesterol,TC)、低密度脂蛋白胆固醇(low-density lipoprotein cholesterol,LDL-C)、高密度脂蛋白胆固醇(high-density lipoprotein cholesterol,HDL-C)、三酰甘油(triglycerides,TG)、空腹血糖(fasting blood glucose,FBG)、空腹胰岛素(fasting serum insulin,INS)、卵泡刺激素(follicle stimulating hormone,FSH)、黄体生成素(luteinizing hormone,LH)、睾酮(testosterone,T)、催乳素(prolactin,PRL)、雌二醇(estrogen,E2);计算体质量指数(body mass index,BMI)、腰臀比(waist hip ratio,WHR)、黄体生成素与卵泡刺激素的比值(LH-to-FSH ratio,LH/FSH);采用稳态模型评估的胰岛素抵抗指数(homeostasis model assessment insulin resistance,HOMA-IR),按血清TSH浓度将其分为2组:A组71例,TSH<2.5mIu/L;B组39例TSH≥2.5 mIu/L;比较2组上述各项指标的差异及TSH与各项指标间的相关性。结果 B组(TSH≥2.5 mIu/L)PCOS患者的WHR及LDL高于A组(TSH<2.5 mIu/L),差异有统计学意义(P<0.05)。TSH浓度的升高与腰臀比、血清总胆固醇、低密度脂蛋白胆固醇、PRL浓度呈正相关。2组间其他临床、代谢指标相比无统计学意义(P>0.05)。结论 TSH与脂代谢指标有相关性,TSH≥2.5 mIu/L的PCOS患者,脂代谢发生了显著的变化。 Objective To investigate the differences in clinical features , endocrine metabolic parameters of polycystic ovary syndrome patients with different levels of serum thyroid-stimulating hormone .Methods One hundred and ten PCOS patients were enrolled . Height , weight , waist circumference , hip circumferences were measured . Chemiluminescence was applied for measuring thyroid-stimulating hormone(TSH), total cholesterol(TC), low density lipoprotein(LDL), high density lipoprotein(HDL), triglyceride(TG), fasting blood-glucose(FBG), fasting insulin(INS), follicle-stimulating hormone(FSH), luteinizing hormone(LH), testosterone(T), prolactin(PRL) and estradiol(E2);Body mass index(BMI), waist-to-hip circumference ratio(WHR), LH-to-FSH ratio(LH/FSH) were calculated;The insulin resistance index evaluated by steady-state model ( HOMA-IR);all patients were divided into two groups according to serum thyroid-stimulating hormone:group A had 71 cases with TSH〈2.5 mIu/L, as group B of 39 cases with TSH≥2.5 mIu/L; all the hormone parameters mentioned above were compared between group A and B , and the correlation with TSH .Results The WHR and LDL in group B(TSH≥2.5 mIu/L) is significantly higher than that of the patients in group A (TSH〈2.5 mIu/L).The increase of TSH concentration positively correlates to an increase of WHR , TC, LDL-C and PRL.No significant differences are shown in other clinical and&amp;nbsp;metabolic indicators.Conclusion There was a significant correlation between TSH and lipid metabolic parameters .Women with polycystic ovary syndrome and with thyroid-stimulating hormone≥2.5 mIu/L had significantly endocrine and metabolic changes .
出处 《首都医科大学学报》 CAS 2014年第4期424-427,共4页 Journal of Capital Medical University
基金 国家外专局引智项目(GDJ20141100017) 北京市卫生系统高层次卫生技术人才培养计划项目(2009-3-52) 首都医科大学附属北京妇产医院 北京妇幼保健院学科带头人项目(2013-1)~~
关键词 多囊卵巢综合征 促甲状腺激素 脂代谢 polycystic ovary syndrome thyroid-stimulating hormone lipid metabolism
  • 相关文献

参考文献13

  • 1丰有吉,沈铿.妇产科学[M].北京:人民卫生出版社,2011:73-74.
  • 2Kaliaperumal R,William E,Selvam T,et al.Relationship between lipoprotein(a)and thyroid hormones in hypothyroid patients[J].Clin Diagn Res,2014,8(2):37 39.
  • 3Morgante G,Musacchio M C,Orvieto R,et al.Alterations in thyroid function among the different polycystic ovary syndrome phenotypes[J].Gynecol Endocrinol,2013,29(11):967 969.
  • 4Du D,Li X.The relationship between thyroiditis and polycystic ovary syndrome:a Meta-analysis[J].Int J Clin Exp Med,2013,6(10):880 889.
  • 5Garelli S,Masiero S,Plebani M,et al.High prevalence of chronic thyroiditis in patients with polycystic ovary syndrome[J].Eur J Obstet Gynecol Reprod Biol,2013,169(2):248 251.
  • 6裴友娟,王蔼明,赵勇,闫玲,李敏.多囊卵巢综合征合并亚临床甲状腺功能减低患者胰岛素水平及血脂变化的研究[J].生殖医学杂志,2013,22(4):285-290. 被引量:15
  • 7Ganie M A,Laway B A,Wani T A,et al.Association of subclinical hypothyroidism and phenotype,insulin resistance,and lipid parameters in young women with polycystic ovary syndrome[J].Fertil Steril,2011,95(6):20392043.
  • 8Huang R,Zheng J,Li S,et al.Subclinical hypothyroidism in patients with polycystic ovary syndrome:Distribution and its association with lipid profiles[J].Eur J Obstet Gynecol Reprod Biol,2014,177:52 56.
  • 9Dittrich R,Kajaia N,Cupisti S,et al.Association of thyroid-stimulating hormone with insulin resistance and androgen parameters in women with PCOS[J].Reprod Biomed Online,2009,19(3):319 325.
  • 10Benetti-Pinto C L,Berini Piccolo V R,Garmes H M,et al.Subclinical hypothyroidism in young women with polycystic ovary syndrome:an analysis of clinical,hormonal,and metabolic parameters[J].Fertil Steril,2013,99(2):588 592.

二级参考文献29

  • 1贾伟平.代谢综合征与胰岛素抵抗[J].中华妇产科杂志,2004,39(9):643-645. 被引量:32
  • 2黄绵清,薛冀苏,幸思忠,谢昌辉.亚临床甲状腺功能减退患者同型半胱氨酸水平与冠状动脉粥样硬化的关系[J].中国老年学杂志,2006,26(4):455-456. 被引量:24
  • 3张玉传,李宗清,谢庆环.代谢综合征与心血管病的关系及治疗研究[J].滨州医学院学报,2006,29(6):434-436. 被引量:10
  • 4Archer JS,Chang RJ. Hirsutism and acne in polycystic ovary syndrome[J]. Best Pract Res Clin Obstet Gynaecol,2004,181 737-754.
  • 5Velkoska-Nakova V, Krstevska B, Bosevski M, et al. Dyslipidaemia and hypertension in patients with subclinical hypothyroidism[J]. Prilozi, 2009,30 : 93-102.
  • 6Ferreira MM,Teixeira Pde F,Mansur VA,et al. Ambulatory blood pressure monitoring in normotensive patients with subclinical hypothyroidism[J]. Arq Bras Cardiol, 2010,94 : 806-812.
  • 7中华人民共和国卫生部医疗服务标准专业委员会.2011年中华人民共和国卫生部,卫生行业标准:多囊卵巢综合症诊断[S].2011.
  • 8Surks MI, Ortiz E, Daniels GH, et al. Subclin!eal thyroid disease: scientific review and guidelines for diagnosis and management[J]. JAMA, 2004,291 : 228-238.
  • 9Hong Y, Yang D, Liu W, et al. Dyslipidemia in relation to body mass index and insulin resistance in Chinese women with polycystic ovary syndrome[J]. Biol Regul Homeost Agents, 2011,25 : 365-374,.
  • 10Verit FF. High sensitive serum C-reactive protein and it relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrom[J]. Arch Gynecol Obstet,2010,281 : 1009-1014.

共引文献97

同被引文献79

  • 1石玉华,陈子江,唐蓉,盛燕,赵力新.多囊卵巢综合征患者内分泌及代谢特征研究[J].山东医药,2006,46(26):4-6. 被引量:25
  • 2丰有吉.妇产科学.北京:人民卫生出版社,2011.137.
  • 3林金芳,李昕,苏椿淋.多囊卵巢综合征患者胰岛素抵抗的诊断方法及治疗策略[J].中国实用妇科与产科杂志,2007,23(9):663-667. 被引量:71
  • 4甲状腺疾病诊治指南——甲状腺功能减退症[J].中华内科杂志,2007,46(11):967-971. 被引量:358
  • 5A~Ti~ R, CarminaE, Dewailly D, et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab, 2006, 91(11):4237-45.
  • 6Adams J, Poison DW, Franks S. Prevalence ofpolycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J (Clin Res Ed), 1986, 293(6543):355-9.
  • 7Lamberg BA. Glucose metabolism in thyroid disease. Acta Med Scand, 1965, 178(3):351-62.
  • 8The Rotterdam ESHER/ASRM - Sponsored pens Work Shop Group. Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome. Fertil Steril, 2004, 81 (1): 19-25.
  • 9Wajner SM, Wagner MS, Maia AL. Clinical implications of altered thyroid status in male testicular function. Arq Bras Endocrinol Metabol, 2009, 53(8):976-82.
  • 10Raber W, Nowotny P, Vytiska-Binstorfer E, et al. Thyroxine treatment modified in infertile women according to thyroxine- releasing hormonetesting: 5 year follow-up of 283 women re- ferred after exclusion of absolute causes of infertility. Hum Reprod, 2003, 18(4):707-14.

引证文献10

二级引证文献87

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部